George Soros’ Soros Fund Management disclosed in an SEC filing its holdings as of December 31, 2024. The fund’s new buys during the fourth ...

Citadel has taken a short position worth 305 million pounds ($384.5 million) in GSK stock, representing a 0.51% stake, ...

The biggest fallers on the FTSE 100 were Schroders, down 12p to 371.6p, IAG, down 8.9p to 338.5p, AstraZeneca, down 256p to ...

Moderna (NASDAQ:MRNA) stock drops ~5% as its Q4 2024 results show revenue beat but earnings miss expectations. Read more here ...

Global sectoral equity funds also saw a net $258 million worth of sales, the first weekly outflow in six weeks. Consumer ...

Ascendis Pharma beat Q4 earnings and revenue estimates, driven by a $100M Novo Nordisk deal and Yorvipath's EU launch.

Marine Systems, a key segment for GD, continues to face margin pressure despite robust sales growth, as supply chain ...

Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus ...

NEW YORK - Waste Connections Inc (NYSE: WCN) reported fourth-quarter earnings that missed analyst expectations, with revenue also falling short of estimates. The company's stock edged down 0.2% ...

Presentation Operator Good morning, and welcome to the Interpublic Group 4th-Quarter and Full-Year 2024 Conference Call. All ...

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

Novartis, Eli Lilly and more put on their deal-making caps, Bristol Myers Squibb targets $2 billion in savings through 2027, ...